More than 1 billion people to get Russia’s COVID-19 vaccine in 2020-2021: Ifax cites RDIF
Posted on
A handout photo shows an employee demonstrating vials with “Gam-COVID-Vac” vaccine against the coronavirus disease (COVID-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. Picture taken August 7, 2020. (The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS ATTENTION EDITORS – THIS IMAGE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. MANDATORY CREDIT.)
Sign up for our amNewYork email newsletter to get news, updates, and local insights delivered straight to your inbox!
BY ANDREY OSTROUKH
Russia’s sovereign wealth fund said on Friday that more than one billion people would receive its COVID-19 vaccine “Sputnik-V” in 2020-21, the Interfax news agency reported.
The Russian Direct Investment Fund (RDIF) has already signed two deals to export the vaccine abroad and on the Brazilian state of Bahia on Friday agreed to conduct Phase III clinical trials of the vaccine.
